VAERS reports by lot

Pfizer COVID-19 lot ELO140: VAERS reports

169 VAERS reports list lot ELO140 as a Pfizer COVID-19 vaccine, received between 2020-12-18 and 2024-06-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
169
Reports
8%
Marked serious
3
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)16324%
Neurological11317%
Cardiac / Cardiovascular8412%
Musculoskeletal6510%
Gastrointestinal609%
Dermatological (non-injection-site)538%
Respiratory426%
Injection-site / Local reaction416%
Allergic / Anaphylactic396%
Psychiatric / Neuropsychiatric71%
Thrombotic / Hematological61%

Where reports came from

U.S. state of the reporter, where given (top 12).

Georgia27
Pennsylvania22
California17
Texas15
Michigan13
Kentucky13
Washington8
New York8
New Jersey7
Minnesota6
Illinois6
Ohio4

Reports by month received

2020-1249
2021-0178
2021-0210
2021-037
2021-041
2021-056
2021-062
2021-073
2021-082
2021-093
2021-112
2022-011
2022-031
2022-051
2022-061
2022-111
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.